NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast Tumors

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

1991 • 5,979 citations

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 • 3,493 citations

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1997 • 1,235 citations

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

2002 • 851 citations

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 • 728 citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 • 712 citations

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

2000 • 407 citations

Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?

2002 • 400 citations

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

2001 • 351 citations

Increased Vaccine-Specific T Cell Frequency After Peptide-Based Vaccination Correlates with Increased Susceptibility to In Vitro Stimulation But Does Not Lead to Tumor Regression

1999 • 290 citations

Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.

1998 • 277 citations

Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

2000 • 232 citations

Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events

1999 • 230 citations

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

2001 • 208 citations

Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL

2000 • 172 citations

Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.

1998 • 146 citations

Clinical cancer vaccine trials

2002 • 134 citations

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

2001 • 126 citations

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.

2001 • 123 citations

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele

2000 • 108 citations

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

2000 • 86 citations

Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.

1985 • 79 citations

Cancer-testis antigens: targets for cancer immunotherapy.

1999 • 76 citations

Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

1997 • 52 citations

A member of the melanoma antigen‐encoding gene (MAGE) family is expressed in human skin during wound healing

1994 • 44 citations

Peptide Vaccines for Cancer

2002 • 33 citations

Jungbluth AA, Chen Y‐T, Stockert E., Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues. International Journal of Cancer 2001; 92(6) 856–860.

2001 • 29 citations

Novel Cloning Method for Recombinant Adenovirus Construction in Escherichia coli

1999 • 24 citations

Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

2001 • 16 citations

Benign breast disease: The relationship between its histological features and risk factors for breast cancer

1991 • 11 citations